| dc.contributor.author | Quevedo-Abeledo, Juan C. | |
| dc.contributor.author | Hernández Díaz, Marta | |
| dc.contributor.author | García González, María | |
| dc.contributor.author | Gómez Bernal, Fuensanta | |
| dc.contributor.author | Almeida Santiago, Cristina | |
| dc.contributor.author | Heras Recuero, Elena | |
| dc.contributor.author | De Vera-González, Antonia | |
| dc.contributor.author | González Delgado, Alejandra | |
| dc.contributor.author | Abreu González, Pedro | |
| dc.contributor.author | Tejera Segura, Beatriz
f | |
| dc.contributor.author | Martín González, Candelaria | |
| dc.contributor.author | González-Gay Mantecón, Miguel Ángel | |
| dc.contributor.author | Ferraz Amaro, Iván | |
| dc.contributor.other | Universidad de Cantabria | es_ES |
| dc.date.accessioned | 2025-10-17T09:09:37Z | |
| dc.date.available | 2025-10-17T09:09:37Z | |
| dc.date.issued | 2025 | |
| dc.identifier.issn | 2076-3921 | |
| dc.identifier.uri | https://hdl.handle.net/10902/37901 | |
| dc.description.abstract | 3-Nitrotyrosine (3-NT) is a product of tyrosine nitration mediated by reactive nitrogen species such as peroxynitrite anion and nitrogen dioxide. It serves as an indicator of inflammation, cell damage, and nitric oxide production. Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by multisystem involvement and increased oxidative stress. Notably, cardiovascular (CV) disease has emerged as the leading cause of mortality among SLE patients. Our objective was to investigate the association between serum 3-NT levels and a wide range of disease characteristics in patients with SLE, with a particular emphasis on CV comorbidity. A total of 214 patients with SLE were enrolled. The serum levels of 3-NT as well as the activity (SLEDAI) and damage index (SLICC-SDI) scores, full lipid profile, insulin resistance indices, and carotid subclinical atherosclerosis were assessed. Multivariable linear regression analysis was carried out to study the relationship between 3-NT and clinical and laboratory disease characteristics, especially focusing on CV comorbidities. Except for body mass index, which showed a significant positive correlation, the demographic data and traditional CV risk factors did not correlate with 3-NT. After multivariable adjustments, several disease characteristics, including the disease duration, activity and damage indices, and autoantibody profile, showed significant positive associations with 3-NT. Regarding CV characteristics, several lipid profile molecules showed significant relationships with 3-NT. This was not the case for insulin resistance and subclinical atherosclerosis. Remarkably, patients with a high CV risk by SCORE2 showed higher 3-NT values compared to those with a low risk, although after the multivariable adjustment, this relationship was attenuated (but still showed a trend). In conclusion, serum 3-NT levels demonstrated significant positive correlations with multiple disease characteristics, including the disease activity and damage and the autoantibody profile. The lipid pattern in the SLE subjects also significantly and independently correlated with the 3-NT values. Our findings highlight the pathophysiological role of 3-NT specifically, and peroxidation in general, in patients with SLE. | es_ES |
| dc.description.sponsorship | This study has been funded by a grant to IF-A by Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC) through the project PIFIISC23/07. Professor Gonzalez-Gay is
funded by the Spanish Research Network RICORS—RD24/0007/0031, through Next Generation EU
funds, which support the initiatives of the Recovery and Resilience Mechanism (MRR). | es_ES |
| dc.format.extent | 14 p. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | Antioxidants, 2025, 14(6), 739 | es_ES |
| dc.subject.other | 3-nitrotyrosine | es_ES |
| dc.subject.other | Systemic lupus erythematosus | es_ES |
| dc.subject.other | Disease damage | es_ES |
| dc.subject.other | Cardiovascular disease | es_ES |
| dc.title | Serum 3-nitrotyrosine in the cardiovascular disease of patients with systemic lupus erythematosus | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherVersion | https://doi.org/10.3390/antiox14060739 | es_ES |
| dc.rights.accessRights | openAccess | es_ES |
| dc.identifier.DOI | 10.3390/antiox14060739 | |
| dc.type.version | publishedVersion | es_ES |